Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative effect of remimazolam in mechanically ventilated septic shock patients
ChiCTR2100045953Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in septic shock (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Richmond Agitation-Sedation Scale (RASS) score, Critical Care Pain Observation Tool (CPOT) score and 2 more. Started Sep 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2100045953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045953.